About
1.57USD+0.12 +8.28%
Closed • Updated at 13:37 GMT+00:00Market Cap$15.46M
Volume86.4K
Beta2.05
RSI52.48
In8bio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 6 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
Apr 3 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 12 2026
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
Feb 24 2026
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
Google Übersetzer